Search

everythinglearnresearchcommunity

for

Search:↓

Doctors need to be better prepared to assess and treat obesity in patients.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Suppressing certain hormones might help prevent prostate cancer.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

A woman with severe angioedema improved significantly after treatment with rituximab.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.